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Abstract 
A series of dehydroacetic acid difluoroboron complexes functionalized by a phenyl ring or an 
electroactive core (tetrathiafulvalene or ferrocene) were synthesized and characterized. The 
redox properties of these derivatives have been analyzed by cyclic voltammetry and the 
molecular structures of some of the difluorobon complexes are presented and discussed. The 
photophysical properties of selected difluoroboron complexes were determined in solution 
and in the solid state evidencing an AIEE (Aggregation Induced Enhancement Emission) 
phenomenon. 
Keywords 
Dehydroacetic acid, Tetrathiafulvalene, Ferrocene, Boron difluoride complex 
1. Introduction 
Dehydroacetic acid (DHA) has mainly been investigated as precursor of various 
heterocyclic compounds of potential biological interest.1 In addition due to its planar 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
2 
structure, its reactivity and also its ability to act as a chelating ligand, this synthon could be 
used as a coordinating part in precursor of molecular materials based on tetrathiafulvalene 
(TTF) for example.2 Indeed, DHA and the Schiff base of DHA exhibit similar binding sites as 
the well-known acetylacetonate group (acac) and thus can complex numerous metallic ions.3,4
Besides metallic ions, DHA and its Schiff base can also complex difluoroboron moiety (Chart 
1). The formation of such difluoroboron complexes present two advantages: (i) it enhances 
the reactivity of DHA itself and (ii) some of these derivatives can exhibit fluorescence 
properties.5  
Chart 1
Our current interest in the synthesis of various electroactive ligands containing the TTF 
core for the elaboration of molecular materials,6 prompted us to investigate the possibility to 
graft, on the DHA, this electroactive moiety. The TTF7 is not the only electrophore which 
exhibits easily accessible and reversible oxidation processes, indeed the ferrocene (Fc)8 is also 
easily oxidized to the ferrocenium ion. We reported the synthesis of a TTF functionalized by a 
DHA-BF2 moiety where the fluorophore and the electrophore were connected thanks to the 
reaction of TTF-hydrazone with DHA.9  
Herein we investigated the synthesis of DHA-BF2 and Schiff base of DHA-BF2
functionalized either by an electrophore, the TTF and the Fc, or by a phenyl group in order to 
analyse the influence of the electrophore on the fluorophore properties. For that purpose, three 
approaches were used: i) Wittig reaction at the 6 position involving the aldehydes bearing an 
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electroactive unit and a phosphonium salt of DHA, ii) condensation reactions of these 
aldehydes with DHA-BF2 at the acetyl position and iii) condensation of the aldehydes on the 
DHA- hydrazone. Three different aldehydes were used, two with an electroactive unit (Fc and 
TTF) and one which could serve as a reference: benzaldehyde. Depending on the reaction 
used, the spacer group between the DHA moiety and the electroactive part will be different as 
well as the position of the connecting part on the DHA core (Chart 2). 
Chart 2 
2. Results and discussion 
Wittig olefination starting from triphenylphosphonium salt 1 enabled us to introduce 
the electroactive moiety on the methyl group at the 6 position of DHA.10 The addition of two 
equivalents of sodium methoxide to salt 1 generates the corresponding ylide which reacts with 
ferrocenecarboxaldehyde (Fc-CHO), trimethyltetrathiafulvalene carboxaldehyde (Me3TTF-
CHO) and benzaldehyde to afford compounds 2a, 2b and 2c10 in 22%, 57% and 48% yield 
respectively (Scheme 1). The addition of an excess of Et2O.BF3 to a toluene solution of 2a-c
under inert atmosphere afforded the corresponding difluoroboron complexes 3a-c in very 
good yields as colored solids. Purification cannot be performed by column chromatography as 
a large amount of these complexes 3a-c get stuck on silica. The other part which was eluted 
correspond to the starting material 2a-c indicating, that upon chromatography, these 
difluoroboron complexes undergo decomplexation. Moreover, compounds 2b and 3b are 
poorly soluble in usual organic solvents. The 1H NMR spectra of these derivatives 2a-c and 
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3a-c exhibit two doublet signals associated with the protons of the formed ethylenic bridge 
with a coupling constant of 15-17 Hz which indicate a trans coupling across the double 
bond.11 Disappearance of the hydroxyl signal (δ = 16.6 ppm) confirms the formation of 
complexes 3. 
Scheme 1. 
The second strategy that we studied in order to graft an electroactive core to a DHA-
difluoroboron complex consists in the use of 3-acetyl-6-methyl-2-oxo-2H-pyran-4-yl 
difluoroborate 4 as starting material. Indeed, DHA-difluoroboron complex 4 in the presence 
of various aldehydes in acetic anhydride medium is known to give condensation compound at 
the acetyl position.12 Moreover, compared with DHA itself the reactivity of the methyl group 
of the acetyl moiety is considerably increased by the presence of the boron difluoride 
complex. Thus, we prepared the complex 4 through the reaction of boron trifluoride diethyl 
etherate with dehydroacetic acid.12 Then by heating the aldehydes, Fc-CHO, Me3TTF-CHO or 
benzaldehyde with complex 4 in acetic anhydride, we formed the targeted complexes 5a-c as 
green solids, in 60 % yield for 5a but in lower yields for 5b-c, 7 and 12% respectively 
(Scheme 2). This difference in the yields can be easily explained by the different work up 
used to obtain these complexes. Indeed, 5a precipitated in the medium while for 5b and 5c 
purification by column chromatography was performed and as already mentioned for 3a-c, 
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upon purification by column chromatography decomplexation of 5b-c partially occur. On the 
other hand, it is also possible to form the corresponding uncomplexed derivatives 6a-b in 
good yields (64-75%) through the hydrolysis of 5a-b in ethanol in the presence of Na2CO3.12
Here again, analyses of the 1H NMR spectra indicate that the ethylenic bridge formed is under 
the trans configuration as a typical 3Jtrans coupling constant of 15-16 Hz is observed. The 
influence of the electron donating ability of the R group can also be observed on these spectra 
as the chemical shift observed for these ethylenic protons is downfield for the benzene 
derivatives compared with the one bearing a Fc or a TTF core. 
Scheme 2. 
Crystals suitable for X-ray diffraction studies have been obtained for compounds 5a and 5b
by slow concentration of a dichloromethane solution. The molecular structures of 5a and 5b
are represented in Figure 1 and selected bond lengths and bond angles are collected in Table 
1. The DHA-boron moieties in compounds 5a and 5b exhibit similar trends: an overall flat 
geometry with the boron out of the plane with the six-membered difluoroboron ring folded 
along the O•••O axis with an angle of 20.8° and 17.3° for complexes 5a and 5b. Within both 
structures, the DHA boron moiety is connected to the electroactive part with a C=C bond 
under a trans configuration. The geometry of the TTF in complex 5b is almost planar as the 
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folding angles along the S•••S axis are only 0.04 and 2.82°. The bond lengths of the TTF core 
are those expected for a neutral TTF (central C=C of 1.346(6) Å).  
      
Fig. 1. Molecular structure of 5a (left), 5b (right)
Table 1. Comparison of selected bond lengths in Å and angles in ° of the chelate ring in 
complexes 5a and 5b. 
Bond lengths 5a 5b Bond angles 5a 5b 
C15-C16 1.350(4) 1.352(5) C14-C15-C16 122.5(3) 121.4(3) 
C14-C15 1.425(3) 1.425(5) O13-C14-O15 116.7(2) 117.1(3) 
C14-O13 1.304(3) 1.302(4) O13-C14-C1 118.7(2) 118.9(3) 
C1-C14 1.440(4) 1.421(5) C14-C1-C6 118.8(2) 119.2(3) 
C1-C6 1.397(3) 1.414(5) C1-C6-O9 122.2(2) 121.9(3) 
C6-O9 1.305(3) 1.303(4) C6-O9-B10 121.2(2) 121.3(3)
O9-B10 1.483(4) 1.503(5) O9-B10-O13 110.5(2) 110.6(3) 
B10-O13 1.481(3) 1.476(5) B10-O13-C14 123.5(2) 124.3(3) 
? ? ? ? ? ?
 For the preparation of the target derivatives through the third approach, we prepared 
DHA-hydrazone 7 according to literature procedure by adding one equivalent of hydrazine 
monohydrate to an ethanolic solution of DHA.13 The condensation reaction occurs 
immediately and an abundant precipitate appears in the media at room temperature to give the 
corresponding hydrazone 7. Crystals suitable for an X-ray diffraction study were obtained for 
7 and the molecular structure is shown in Fig. 2. DHA-hydrazone 7 exhibits a planar 
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geometry with the establishment of intramolecular hydrogen bonding between the O-H and 
the sp2 N atom of the hydrazone (1.821(1) Å) forming a pseudo six membered cycle.  
   
Fig 2. Molecular structure of DHA-hydrazone 7 
Reactions were carried out between DHA-hydrazone 7 and the three aldehydes (Fc-CHO, 
Me3TTF-CHO and benzaldehyde). These reactions, with the electroactive moieties were 
performed in THF in the presence of HCl to afford 8a and 8b in 74% and 53 % yield 
respectively as dark colored solids (Scheme 3).9 The reaction of DHA-hydrazone 7 with 
benzaldehyde was carried out in refluxing EtOH and led to the desired derivative 8c in 75 % 
yield. In order to prepare the difluoroboron complex of the derivatives 8a-c, we added an 
excess of Et2O.BF3, in the presence of triethylamine, to a solution of 8a-c in dichloromethane 
under inert atmosphere. The difluoroborane complexes 9a-c were isolated after purification 
by column chromatography. It is worth noting that in this case decomplexation upon column 
chromatography was not observed. 
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Scheme 3. 
 Crystals suitable for X-ray diffraction studies have been obtained for compounds 8a
and 9a and their molecular structures are represented in Figure 3. Within compound 8a, 
analysis of the bond lengths of the linker between the DHA and the ferrocene moieties 
together with the finding of a hydrogen atom on N13, which was introduced in the structural 
model through Fourier difference maps analysis, indicate that the linker is not an azino 
structure but a hydrazone one. It is worth noting that for the starting material, DHA-
hydrazone, the crystal structure determination led to the other tautomer, the imine form. 
Actually it is known that, imine-enamine tautomerism of pyronic derivatives such as DHA 
exists. Moreover, depending on the substituent, either the enamine or the imine's form is 
favored (Scheme 4).14 Herein, the enamino ketone form for 8a is obtained. Intramolecular 
hydrogen bonding is observed between the N-H and the O atom within this structure leading 
to a six-membered cycle. Except for the ferrocenyl group the molecule 8a exhibits a planar 
skeleton. 
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Scheme 4. 
 Besides the orientation of the ferrocenyl group with regard to the DHA moiety the 
molecular shape of the difluoroboron complex 9a is very similar to the one of the starting 
ligand 8a. Indeed the ferrocenyl groups are pointing in opposite direction. Variations can also 
be noticed on the bond lengths and bond angles mainly on the chelate ring. Selected bond 
lengths and angles of the chelate rings are collected in Table 2. Within the complex 9a, the 
C16-C21 bond is shortened compared to ligand 8a (ca.0.05 Å) while the C21-O24 bond is 
lengthened (ca. 0.04 Å). Due to the presence of the difluoroboron moiety, the bond angles of 
the chelating moiety are different. Otherwise, in complex 9a, the chelate ring is less distorted 
than complexes 2a and 2b as the torsion angle is only 7.19(24) °. 
Table 2. Comparison of selected bond lengths in Å and angles in ° of the chelate ring in 
ligand 8a and complex 9a. 
Bond lengths 7 8a 9a Bond angles 7 8a 9a 
C11-N12 1.288(2) 1.285(5) C10-C11-N12 122.99(14) 117.1(3) 
N12-N13 1.416(2) 1.3918(17) 1.417(4) C11-N12-N13  111.88(12) 117.6(3) 
N13-C14 1.312(2) 1.3225(19) 1.331(5) N12-N13-C14 122.78(15) 123.40(13) 113.1(3)
C14-C16 1.442(2) 1.432(2) 1.440(5) N13-C14-C16 117.71(15) 116.40(13) 117.4(4) 
C16-C21 1.444(2) 1.442(2) 1.388(6) C14-C16-C21 121.01(14) 121.11(13) 120.1(4)
C21-O24 1.266(2) 1.2645(18) 1.305(4) C16-C21-O24 123.14(15) 123.36(13) 123.2(3) 
O24-B25 - 1.465(5) C21-O24-B25 - 124.6(3)
B25-N13  - 1.572(6) O24-B25-N13  - 108.8(3) 
B25-N13-C14 - 125.1(3)
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Fig. 3. Molecular structure of 8a (left) and 9a (right). 
In order to study the influence of the complexation on the donating ability of the electroactive 
moieties, we performed electrochemical investigations on the starting ligands and on the 
difluoroboron complexes. For all the ferrocene derivatives one reversible monoelectronic 
wave is observed corresponding to the oxidation of the ferrocene moiety into the ferrocenium 
species. For all the TTF derivatives, two reversible monoelectronic oxidation waves are 
observed corresponding to the formation of the radical cation and the dication species 
respectively. In both series, the TTF and the ferrocene, the presence of the boron complex 
induces a shift of the oxidation potentials towards more positive potentials indicating the 
electron withdrawing effect of the complexation with boron difluoride (Table 3). Similar 
effect has been observed previously on TTF-acetylacetonate complexes of difluoroboron.15
Table 3. Redox potentials E1/2, CH2Cl2, Pt, SCE, TBAPF6 0.1M, 100 mVs-1
Ligands E11/2 E21/2 Complexes E11/2 E21/2
2a 0.58 3a 0.63 
2b 0.37 0.85 3b 0.45 0.91 
6a 0.61  5a 0.74  
6b 0.41 0.90 5b 0.48 0.94 
8a 0.64  9a 0.67  
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8b 0.38 0.87 9b 0.43 0.94 
Absorption and emission spectra of selected compounds have been recorded in 
dichloromethane solutions and the data are gathered in Table 4. Absorption spectra of 
compound 4 display a strong absorption band centered at 327 nm together with a weaker one 
at 258 nm (Figure 4). These absorption bands are attributed to n-π* and π-π* transitions 
centered on the DHA-BF2 core. Interestingly, this compound was found to be highly 
luminescent in solution under irradiation at 327 nm. An emission band centred at 360 nm 
extending from 330 nm to 450 nm in the visible region has been observed and a high 
fluorescence quantum yield around 74.5% has been determined relatively to quinine sulfate. 
The excitation spectra perfectly match absorption spectra, which is in line with a unique 
excited state and the weak Stokes’ shifts (33 nm) observed is in good agreement with a singlet 
emitting state.  
Figure 4. Absorption, emission (λex = 300 nm) and excitation (λem = 360 nm) of compound 4
in dichloromethane (c = 10-5 mol.L-1). 
Table 4. Optical data measured in dichloromethane solution at 298 K. 
Compounds λabs
[a]
(nm) 
ε[a] 
(M-1.cm-1) 
λF
(nm) Φsolution 
[b]
2a 534 
387 
5500 
20800 
- - 
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2b 567 
378 
330 
292
10000 
32000 
18000 
17000
- - 
3a 606 
420 
307
3500 
11000 
1800
- - 
3b 636 
410 
385
7500 
16200 
16900
- - 
3c 395 39000 - - 
4 327 
258 
26000 
6000 
360 0.745 
5a 645 
419 
330
14500 
57500 
12500
358 0.007 
5b 799 
432 
324
78000 
26000 
14000
- - 
5c 406 
339 
40000 
11500 
450 0.004 
6a 550 
365 
7500 
32500 
- - 
6b 600 
368 
8200 
32600 
- - 
8a 483 
376 
361 
248
22000 
122000 
133000 
86000
- - 
8b 525 
383 
369
6600 
36300 
34400
- - 
8c 379 
365 
35000 
39000 
- - 
9a 500 
353 
289 
19000 
111000 
45000 
- - 
9b 558 
369 
6700 
34000 
- - 
9c 358 26500 440 0.002 
Fc-CHO 460 
338 
268 
6050 
14000 
69700 
- - 
  [a] c ∼ 10-5 M; [b] reference quinine sulfate (φref = 0.546 in H2SO4 1N)16
The two absorption maxima of compound 5c are significantly red shifted compared to 4 and 
are observed at 406 and 339 nm. This red shift is assigned to the extension of the π-
conjugation induced by the presence of styryl fragment at the acetyl position of the DHA-
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
13 
difluoroboron complex. However, the introduction of a styryl arm appears to be detrimental 
for the luminescence properties of the DHA-BF2 core and only a weak emission centred at 
450 nm is now observed upon excitation at 390 nm with a low quantum yield around 0.4 %. 
The replacement of the phenyl ring by a ferrocenyl donor group in 5a weakly affect the 
position of these two absorption bands but an additional intense and broad absorption band is 
observed at 645 nm. This new band is attributed to a charge-transfer band (CT band) from the 
ferrocenyl donor to the DHA-BF2 acceptor. It should be mentioned that Fc-CHO absorbs at 
much lower wavelengths. A weak emission at 358 nm was detected with compound 5a upon 
excitation at 300 nm. The grafting of a ferrocenyl group does not really affect the 
luminescence properties the DHA-BF2-styryl core. Electrochemical or chemical oxidation 
(with NOBF4) of compound 5a did not change the luminescence properties. An irreversible 
extinction of the luminescence was observed upon reduction at -1V vs ECS, likely attributed 
to the degradation of the compound. With a TTF fragment (5b), a CT band is also observed 
but at higher wavelength (799 nm) which is in line with a stronger donor character compare to 
a ferrocenyl fragment. Introduction of a styryl arm at the 6 position was also found to be 
detrimental for the luminescence properties of the DHA-BF2 core since no emission could 
have been detected with 3a and 3c compounds. It can also be observed that the extension of 
the π-conjugation, i.e. bathochromic shift of the absorption bands, is much more effective at 
the acetyl position than in the 6 position. Removal of the BF2 fragment (compounds 2 and 6) 
leads to a blue shift of the absorption bands. This behaviour is likely attributed to a decrease 
of the rigidity and planarity between the DHA fragment and the carbonyl group. The same 
observation can also be made within the hydrazine series. The absorption spectra of 8c, the 
DHA-hydrazone derivative carrying a phenyl ring, displays two strong absorption bands at 
365 and 379 nm. 8a carrying a ferrocene moiety shows the same main absorption peaks at 361 
and 376 nm and the expected additional broad CT band due to the presence of the donor 
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fragment on the hydrazone derivative is observed at 483 nm. These two compounds were 
found to be non-luminescent in solution and in the solid state in contrary to the DHA-azino 
derivative 9c carrying a phenyl group and complexed by a BF2 fragment. The absorption 
spectra of 9c displays one main absorption band centred at 358 nm. 9c is weakly luminescent 
in dichloromethane solution (φ = 0.2 %) but interestingly it was found that this compound is 
highly luminescent in the solid state. Upon excitation at 360 nm, this compound shows a 
strong emission from 410 to 700 nm with a maximum centred at 469 nm (Figure 5). The solid 
state quantum yield measured with an integration sphere was found to be around 24 % which 
is 120 times higher than in solution. The luminescence properties of 9c appear to be highly 
sensitive to the aggregation state and in the solid state a strong increase of the luminescence 
intensity is observed. This phenomenon can be described as an Aggregation Induced 
Enhancement Emission (AIEE) due to a restricted intramolecular motion17 or to J stacking.18
More interestingly, the colorimetric coordinate of the emitted light in the CIE diagram were 
found to be x = 0.200 and y = 0.314 which is close to white light (x= 0.33 and y = 0.33). 
Figure 5. Solid state emission of compound 9c under excitation at 360 nm (inset: Photographs 
of a crystal of compound 9c under day light (top) and 254 nm UV light (bottom)). 
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3. Conclusion 
In conclusion, we prepared three types of DHA and DHA-BF2 functionalized at 
different position by a benzene ring or an electroactive molecule (TTF or Fc). It is worth 
noting that the molecules where an azino linker is used to connect the DHA to the 
electrophore are more stable than those involving an ethylenic spacer group especially in the 
case of the boron difluoride complexes. Indeed, dioxaborine cycles can be easily hydrolyzed 
leading to the decomplexation while the enaminoketonato boron is more stable. The 
photophysical behavior of some of these difluoroboron complexes have been investigated. 
The DHA-BF2 was found highly luminescent in solution and we observed that substitution of 
this skeleton induces a significant decrease of the emission properties. Nevertheless, the most 
interesting derivative is the one where a phenyl ring is linked by an azino spacer group to the 
DHA-BF2 moiety. Indeed even if in solution this compound is weakly luminescent, in the 
solid state a strong increase of the luminescence is observed. Moreover, the colorimetric 
coordinate of the light emitted let us infer that a fine tuning of the substituent on this skeleton 
would allowed us to reach the white light.  
4. Experimental section 
4.1. General 
1H NMR, 13C NMR, 11B NMR and 19F NMR spectra were recorded on a Bruker Avance 300 
III spectrometer using CDCl3 as solvent unless otherwise stated. Chemical shifts are reported 
in parts per million. Mass spectra and elemental analysis results were performed by the Centre 
Régional de Mesures Physiques de l’Ouest (CRMPO), Rennes. Melting points were measured 
using a Kofler hot stage apparatus and are uncorrected. Cyclic voltammetry were carried out 
on a 10-3 M solution of the compounds in dichloromethane, containing 0.1 M n-Bu4NPF6 as 
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supporting electrolyte. Voltammograms were recorded at 100 mV.s-1 on a platinum disk 
electrode (1 mm2). The potentials were measured versus Saturated Calomel Electrode. 
Compounds 110, 2c10, 412 and 713 were synthesized according to literature procedure. All the 
reagents were purchased and used without additional purification. UV-Vis spectra were 
recorded using a Cary 100 UV-Vis spectrophotometer (Varian) and CH2Cl2 as solvent. 
Photoluminescence spectra in solution were recorded with a Jobin-Yvon spectrofluorimeter. 
Quantum yields in solution (φsol) were calculated relative to Ru(bipy)3]Cl2 (φ = 0.059 in 
CH3CN). φsol was determined according to the following equation, 
φsol = φref × 100 × [(Ts × Ar)/(Tr × As)] × [(ns/nr)2] 
where, subscripts s and r refer respectively to the sample and reference. The integrated area of 
the emission peak in arbitrary units is given as T, n is the refracting index of the solvent (n = 
1.3404 for acetonitrile, n = 1.4242 for dichloromethane and n = 1.4305 for DMF) and A is the 
absorbance. Absolute quantum yield and CIE coordinates were measured with a Hamamatsu 
C9920-03G system. 
4.2. Synthesis and characterization 
General procedure for the synthesis of 2a, b. To a solution of phosphonium salt 1 (0.75 mmol, 
382 mg) in 10 mL of dry DMF at 0°C was slowly added 1.5 mL (1.5 mmol) of freshly 
prepared 1M sodium methanolate solution under inert atmosphere. The reaction was kept at 
room temperature for ½ h and ferrocenecarboxaldehyde (0.7 mmol, 150 mg) or 
Me3TTFcarboxaldehyde (0.7 mmol, 192 mg) in dry DMF (10 mL) was slowly added. The 
solution was left overnight under stirring. The medium was acidified with 1M HCl solution 
(0.8 mL, 0.8 mmol) and DMF was evaporated. The resulting solid was extracted with CH2Cl2
and washed with water and subjected to column chromatography on silica gel with CH2Cl2/PE 
(3/1) as eluent. 
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2a (56 mg) was obtained as a deep purple solid in 22 % yield; mp 172-174°C; 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 2.70 (s, 3H, CH3), 4.20 (s, 5H, Cp), 4.52 (m, 2H, Cp), 4.62 
(m, 2H, Cp), 5.93 (s, 1H, =CH), 6.21 (d, 1H, J=15Hz, =CH), 7.59 (d, 1H, J=15Hz, =CH), 
16.63 (s, 1H, OH); 13C NMR (CDCl3, 75 MHz) δ (ppm) 30.3, 68.7, 70.0, 71.7, 79.3, 99.2, 
100.1, 114.8, 142.32, 161.1, 164.1, 180.8, 204.7; UV-Vis λ (ε) = 387 nm (20 800), 534 nm (5 
500); IR (cm-1) ν = 1712, 1610, 1545; HRMS calc. for M+. (C19H1656FeO4) : 364.0398, found : 
364.0399. 
 2b (169 mg)  was obtained as a deep purple solid in 57% yield; mp > 250°C 
(decomp.); 1H NMR (CDCl3, 300 MHz) δ (ppm) 1.96 (s, 6H, CH3), 2.26 (s, 3H, CH3), 2.68 (s, 
3H, CH3), 5.80 (d, 1H, J=15Hz, =CH); 5.98 (s, 1H, =CH), 7.36 (d, 1H, J=15Hz, =CH), 16.61 
(s, 1H, OH); UV-Vis λ (ε) = 292 nm (17 000), 330 nm (18 000), 378 nm (32 000), 567 nm 
(10 000); IR (cm-1) ν = 1703, 1593, 1542, 1519; HRMS calc. for M+. (C18H16O4S4) : 
423.9931, found : 423.9926.
General procedure for the synthesis of 3a-c. To a solution of 2 (0.25 mmol, 91 mg of 2a, 106 
mg of 2b, 64 mg of 2c) in toluene (5 mL) was added dropwise at room temperature and under 
inert atmosphere 63 μL of boron trifluoride etherate (0.5 mmol). A black solid precipitated 
immediately which was filtered under vacuum, washed with toluene and dried. For 3c, the 
reaction was refluxed 1h and the yellow precipitate was filtrated under vacuum, washed with 
toluene and dried.  
 3a (98 mg) was obtained as a deep green solid in 95% yield; mp>250°C (decomp.); 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 2.84 (s, 3H, CH3), 4.23 (s, 5H, Cp), 4.64 (m, 2H, Cp), 4.69 
(m, 2H, Cp), 6.04 (s, 1H, =CH), 6.27 (d, 1H, J=15Hz, =CH), 7.84 (d, 1H, J=15Hz, =CH); 13C 
NMR (CDCl3, 75 MHz) δ (ppm) 26.5, 69.9, 70.8, 73.6, 77.3, 99.2, 107.5, 113.9, 148.4, 158.7, 
168.6, 178.0, 197.7; 11B NMR (CDCl3, 96 MHz) δ (ppm) -0.03; 19F NMR (CDCl3, 282 MHz) 
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δ (ppm) -141.3; UV-Vis λ (ε) = 307 nm (1800), 420 nm (11 000), 606 nm (3 500); IR (cm-1) ν
= 1749, 1580, 1496; HRMS calc. for M+. (C19H15O4F211B56Fe) : 412.0381, found : 412.0380. 
 3b (111 mg) was obtained as a deep purple solid in  94% yield; mp = 220 °C 
(decomp.); 1H NMR (CD3CN, 300 MHz) δ (ppm) 2.31 (s, 3H, CH3), 2.65 (s, 6H, CH3), 2.79 
(s, 3H, CH3), 6.22 (d, 1H, J=15Hz, =CH), 6.49 (s, 1H, =CH), 7.60 (d, 1H, J=15Hz, =CH). 11B 
NMR (CDCl3, 96 MHz) δ (ppm) -0.99; 19F NMR (CDCl3, 282 MHz) δ (ppm) -150.6; UV-Vis 
λ (ε) = 385 nm (16 900), 410 nm (16 200), 636 nm (7 500); IR (cm-1) ν = 1740, 1620, 1458; 
HRMS calc. for M+. (C18H15O4F211BS4) : 471.9914, found : 471.9924. 
3c (70 mg) was obtained after precipitation in CH2Cl2 as yellow crystals in 92 % yield; 
mp 240°C (decomp.); 1H NMR (CDCl3, 300 MHz) δ (ppm) 2.89 (s, 3H, CH3), 6.22 (s, 1H, 
=CH), 6.73 (d, 1H, J=17Hz, =CH); 7.42-7.48 (m, 3H, Ar), 7.61 (m,  2H, Ar); 8.83 (d, 1H, 
J=17Hz, =CH); 11B NMR (CDCl3, 96 MHz) δ (ppm) -0.02; 19F NMR (CDCl3, 282 MHz) δ
(ppm) -140.4; UV-Vis λ (ε) = 395 nm (39 000); IR (cm-1) ν = 1756, 1629, 1600, 1509; 
HRMS calc. for [M+H]+ (C15H12O4F211B) : 305.0791, found : 305.0795 
General procedure for the synthesis of 5a-c. To a hot solution of DHA-BF2 4 (216 mg, 1 
mmol) in 3 mL of acetic anhydride (60°C) was added a solution of ferrocenecarboxaldehyde 
(214 mg, 1 mmol)  or a suspension of trimethylTTF-aldehyde (274 mg, 1 mmol) or a solution 
of benzaldehyde (153 μL, 1.5 mmol) in 2 mL of acetic anhydride. The reaction was heated to 
90°C for 45 min. After cooling, the precipitate was filtered and washed with acetic acid and 
water. 
 5a (247 mg) was obtained in 60% yield as a deep green powder; mp 250°C (decomp.); 
1H NMR (CDCl3, 300 MHz) δ (ppm) 2.33 (s, 3H, CH3), 4.30 (s, 5H, Cp), 4.83 (s, 2H, Cp), 
4.93 (s, 2H, Cp), 6.09 (s, 1H, =CH), 7.84 (d, 1H, =CH, J=16 Hz), 8.59 (d, 1H, =CH, J=16 
Hz); 13C NMR (CDCl3, 75 MHz) δ (ppm) 21.1, 71.5, 71.7, 76.1, 79.1, 98.36, 130.1, 114.6, 
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159.3, 160.6, 171.8, 178.4, 179.8; 11B NMR (CDCl3, 96 MHz) δ (ppm) -0.05; 19F NMR 
(CDCl3, 282 MHz) δ (ppm) -143.3; UV-Vis λ (ε) = 330 nm (12 500), 419 nm (57 500), 645 
nm (14 500); IR (cm-1) ν = 1739, 1632, 1591, 1475; HRMS calc. for M+. (C19H15BF256FeO4); 
412.0381, found: 412.0387; Anal. Calcd for C19H15BF2FeO4: C, 55.39, H, 3.67, found C, 
55.65, H, 3.63 %.  
5b was extracted with CH2Cl2 and subjected to column chromatography using first 
CH2Cl2/PE (1/2) and then CH2Cl2 as eluent. 5b (33 mg) was obtained in 7 % yield as a green 
powder; mp >260°C; 1H NMR (CDCl3, 300 MHz) δ (ppm) 1.97 (s, 3H, CH3), 1.98 (s, 3H, 
CH3), 2.37 (s, 3H, CH3), 2.41 (s, 3H, CH3),  6.09 (s, 1H, =CH), 7.42 (d, 1H, =CH, J=15 Hz), 
8.08 (d, 1H, =CH, J=15 Hz); 11B NMR (CDCl3, 96 MHz) δ (ppm) 0.08; 19F NMR (CDCl3, 
282 MHz) δ (ppm) -142.6; UV-Vis λ (ε) = 324 nm (14 000), 432 nm (26 000), 799 nm (78 
000); IR (cm-1) ν = 2920, 1729, 1641, 1583, 1466, 1402; HRMS calc. for M+.
(C18H15BF2O4S4): 471.9909, found: 471.9910. 
5c was purified by column chromatography using CH2Cl2/PE (4/1) as eluent. 5c (36 
mg) was obtained in 12 % yield as a pale yellow powder; mp 254°C (decomp.) ; 1H NMR 
(CDCl3, 300 MHz) δ (ppm)  2.40 (s, 3H, CH3), 6.16 (s, 1H, =CH), 7.46-7.59 (m, 3H, Ar), 
7.78 (m, 2H, Ar), 8.40 (d, 1H, =CH, J=15 Hz), 8.46 (d, 1H, =CH, J=15 Hz); 13C NMR 
(CDCl3, 75 MHz) δ (ppm) 21.4, 103.0, 118.9, 129.2, 129.6, 130.8, 133.7, 134.0, 155.1, 159.0, 
174.3, 180.0, 184.8; 11B NMR (CDCl3, 96 MHz) δ (ppm) 0.14; 19F NMR(CDCl3, 282 MHz) 
δ (ppm) -141.9; UV-Vis λ (ε) = 339 nm (11 500), 406 nm (40 000); IR (cm-1) ν = 2925, 1732, 
1631, 1618, 1539, 1501; HRMS calc. for [M+H]+ (C15H12F2O411B) : 305.0791, found : 
305.0796. 
General procedure for the synthesis of 6a, b. To difluoroborane complex 5a (100 mg, 0.24 
mmol) or 5b (20 mg, 0.042 mmol) was added sodium carbonate (1.0 g, 0.94 mmol) dissolved 
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in a mixture of water (5 mL) and EtOH (5 mL). The medium was refluxed for 2h. The 
reaction mixture was cooled and treated with a solution of hydrochloric acid till pH reached 
6.5–7. The precipitate that formed was filtered, extracted with CH2Cl2, washed with water and 
dried over magnesium sulfate. The product was purified by column chromatography using 
CH2Cl2/PE (4/1) as eluent. 
 6a (65 mg) was obtained as a deep purple powder in 75% yield ; mp 159-160°C; 1H 
NMR (CDCl3, 300 MHz) δ (ppm) 2.25 (s, 3H, CH3), 4.20 (s, 5H, Cp), 4.57 (s, 2H, Cp), 4.68 
(s, 2H, Cp), 5.92 (s, 1H, =CH), 7.86 (d, 1H, =CH, J=16 Hz), 7.99 (d, 1H, =CH, J=16 Hz); 13C 
NMR (CDCl3, 75 MHz) δ (ppm) 20.6, 69.9, 70.1, 72.4, 79.0, 98.9, 102.9, 119.3, 150.0, 161.4, 
167.8, 183.7, 190.9; UV-Vis λ (ε) = 365 nm (32 500), 550 nm (7 500); IR (cm-1) ν = 1716, 
1652, 1609, 1504; HRMS calc. for M+. (C19H1656FeO4): 364.0398, found: 364.0410.  
 6b (11 mg) was obtained as a deep blue powder in 64% yield ; mp > 250°C; 1H NMR 
(CDCl3, 300 MHz) δ (ppm) 1.95 (s, 3H, CH3), 1.96 (s, 3H, CH3), 2.27 (s, 6H, CH3), 5.93 (s, 
1H, =CH), 7.46 (d, 1H, =CH, J=15 Hz), 7.73 (d, 1H, =CH, J=15 Hz), 17.89 (s, 1H, OH); 13C 
NMR (CDCl3, 75 MHz) δ (ppm) 13.8, 14.8, 20.8, 99.6, 102.5, 113.1, 122.7, 123.4, 124.0, 
128.9, 129.6, 133.1, 144.8, 161.1, 168.7, 183.1, 192.0; UV-Vis λ (ε) = 368 nm (32 600), 600 
nm (8 200); IR (KBr, cm-1) ν = 2921, 1716, 1638, 1618, 1509; HRMS calc. for M+.
(C18H16O4S4): 423.9926, found: 423.9930 
General procedure for the synthesis of 8a, b. To a solution of DHA-hydrazone 7 (182 mg, 1 
mmol) in THF (15 mL) was added ferrocenecarboxaldehyde (214 mg, 1 mmol) or 
Me3TTFcarboxaldehyde (274 mg, 1 mmol) and 2 mL of HCl 2M. The reaction mixture was 
refluxed 2h. The solvent was removed under vacuum, the solid was extracted with CH2Cl2, 
washed with water and dried over MgSO4. 
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 8a was purified by column chromatography using CH2Cl2 as eluent to afford a red 
solid in 74% yield (280 mg); mp 154°C ; 1H NMR (CDCl3, 300 MHz) δ (ppm) 2.16 (s, 3H, 
CH3), 2.89 (s, 3H, CH3), 4.23 (s, 5H, Cp), 4.53 (s, 2H, Cp), 4.69 (s, 2H, Cp), 5.75 (s, 1H, 
=CH), 8.20 (s, 1H, =CH), 16.71 (s, 1H, OH); 13C NMR (CDCl3, 75 MHz) δ (ppm) 17.2, 20.0, 
68.8, 69.6, 71.8, 76.5, 95.6, 107.2, 156.4, 163.2, 163.5, 170.9, 184.5; UV-Vis λ (ε) = 248 nm 
(86 000), 361 nm (133 000), 376 nm (122 000), 483 nm (22 000); IR (cm-1) ν = 1707, 1659, 
1600, 1562; HRMS calc. for M+. (C19H18N2O356Fe): 378.0667, found: 378.0672. Anal. Calcd 
for C19H18FeN2O3: C, 60.34, H, 4.80, N, 7.41, found C, 60.04, H, 4.73, N, 7.10 %.  
 8b was purified by column chromatography using CH2Cl2 /MeOH (9.8/0.2) as eluent 
to afford a deep purple powder in 53% yield (232 mg); mp 274 °C; 1H NMR (CDCl3, 300 
MHz) δ (ppm) 1.96 (s, 6H, CH3), 2.17 (s, 3H, CH3), 2.26 (s, 3H, CH3), 2.88 (s, 3H, CH3), 
5.74 (s, 1H, CH), 8.09 (s, 1H, CH=N); 13C NMR (CDCl3, 75 MHz) δ (ppm) 12.7, 12.7, 13.4, 
16.0, 18.9, 95.1, 105.8, 112.1, 121.7, 122.1, 142.6, 142.8, 142.9, 162.0, 162.7, 171.6, 183.6; 
UV-vis λ (ε) 369 nm (34 400), 383 nm (36 300), 525 nm (6 600); IR (cm-1) ν = 1616, 1590; 
HRMS calc. for M+.  (C18H18N2O3S4) 438.0200, found 438.0194. 
Synthesis of 8c. To a solution of DHA-hydrazone 7 (546 mg, 3 mmol) in absolute EtOH (15 
mL) was added benzaldehyde (0.3 mL, 3 mmol). The reaction mixture was refluxed for 3 h. 
The solvent was removed under vacuum and the solid was subjected to column 
chromatography using CH2Cl2/PE (4/1) as eluent to afford 8c (608 mg) in 75% yield as a pale 
yellow powder; mp 199°C; 1H NMR (CDCl3, 300 MHz) δ (ppm) 2.17 (s, 3H, CH3), 3.00 (s, 
3H, CH3), 5.76 (s, 1H, =CH), 7.43-7.52 (m, 3H, Ar), 7.66 (d, 2H, J=8 Hz, Ar); 8.29 (s, 1H, 
N=CH);  13C NMR (CDCl3, 75 MHz) δ (ppm) 17.1, 19.9, 96.0, 107.0, 128.3, 129.0, 131.8, 
132.7, 154.3, 163.1, 163.5, 172.9, 184.6; UV-Vis  λ (ε)  = 365 nm (39 000), 379 nm (35 000); 
IR (cm-1) ν = 2958, 2923, 1702, 1656, 1608, 1574, 1553; HRMS calc. for [M+Na]+
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C15H14N2O3Na : 293.0902, found : 293.0904; Anal. Calcd for C15H14N2O3: C, 66.66, H, 5.22, 
N, 10.36; found C, 66.59, H, 5.10, N, 10.31 %. 
General procedure for the synthesis of 9a-c. An excess of Et2O.BF3 (0.63 mL, 5 mmol) was 
added to a solution of 8a (189 mg, 0.5 mmol) or 8b (220 mg, 0.5 mmol) 8c (135 mg, 0.5 
mmol) containing dry NEt3 (0.21 mL, 1.5 mmol) in 15 mL of dry and degassed CH2Cl2 under 
inert atmosphere. The reaction mixture was stirred at room temperature for 12 h. The organic 
phase was washed with water and dried over MgSO4 and subjected to column 
chromatography using CH2Cl2 as eluent.
 9a (164 mg) was obtained as a red solid in 77% yield; mp 206°C ; 1H NMR (CDCl3, 
300 MHz) δ (ppm) 2.31 (s, 3H, CH3), 2.81 (s, 3H, CH3), 4.32 (s, 5H, Cp), 4.58 (t, 2H, J = 
2Hz, Cp), 4.76 (s, 2H, J = 2Hz, Cp), 6.07 (s, 1H, =CH), 8.63 (s, 1H, =CH); 13C NMR (CDCl3, 
75 MHz) δ (ppm) 17.9, 20.6, 69.4, 70.0, 72.5, 77.2, 96.7, 102.4, 160.5, 164.8, 167.6, 168.8, 
172.3; 11B NMR (CDCl3, 96 MHz) δ (ppm) -19.39; 19F NMR (CDCl3, 282 MHz) δ (ppm) -
136.6; UV-Vis λ (ε) = 289 nm (45 000), 353 nm (111 000), 500 nm (19 000); IR (cm-1) ν = 
1712, 1650, 1609, 1562, 1506; HRMS calc. for M+. (C19H17N2O3F211B56Fe): 426.0650, found: 
426.0660.  
 9b (56 mg) was obtained as a red solid in 23% yield; mp > 260°C ; 1H NMR (CDCl3, 
300 MHz) δ (ppm) 1.96 (s, 6H, CH3), 2.33 (s, 3H, CH3), 2.92 (s, 3H, CH3), 6.06 (s, 1H, 
=CH), 8.65 (s, 1H, =CH); 11B NMR (CDCl3, 96 MHz) δ (ppm) -0.14; 19F NMR (CDCl3, 282 
MHz) δ (ppm) -136.4; UV-Vis λ (ε) = 369 nm (34 000), 558 nm (6 700); HRMS calc. for M+.
(C18H17N2O3F211B): 486.01832, found: 486.0184.  
 9c (95 mg) was obtained as a yellow solid in 60% yield; mp 202°C ; 1H NMR (CDCl3, 
300 MHz) δ (ppm) 2.34 (s, 3H, CH3), 2.96 (s, 3H, CH3), 6.08 (s, 1H, =CH), 7.45-7.57 (m, 3H, 
Ar), 7.86 (d, 2H, J=6 Hz, Ar); 8.78 (s, 1H, =CH); 13C NMR (CDCl3, 75 MHz) δ (ppm) 18.2, 
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20.7, 96.9, 102.4, 129.1, 129.2, 132.8, 132.9, 160.4, 162.4, 169.7, 170.4, 173.0; 11B NMR 
(CDCl3, 96 MHz) δ (ppm) -0.07; 19F NMR (CDCl3, 282 MHz) δ -136.6; UV-Vis λ (ε) = 358 
nm (26 500); IR (cm-1) ν = 1731, 1637, 1510, 1449; HRMS calc. for [M+Na]+
C15H13N2O3F211BNa : 341.0885, found : 341.0884 
4.3. Crystallography 
Single-crystal diffraction data were collected on APEX II Bruker AXS diffractometer, Mo Kα
radiation (λ = 0.71073 Å), for compounds 5a, 5b, 7, 8a and 9a (Centre de Diffractométrie X, 
Université de Rennes, France). The structures were solved by direct methods using the SIR97 
program,19 and then refined with full-matrix least-square methods based on F2 (SHELX-97)20
with the aid of the WINGX program.21 All non-hydrogen atoms were refined with anisotropic 
atomic displacement parameters. H atoms were finally included in their calculated positions. 
Crystal data for 5a: (C19H15BF2FeO4); M=411.97. T=294(2) K; monoclinic P 21/c, 
a=11.323(5), b=10.313(7), c=15.246(9) Å, β=103.71(3) °, V=1729.6(17) Å3, Z=4, d=1.582 
g.cm-3, μ=0.915 mm-1. A final refinement on F2 with 3903 unique intensities and 245 
parameters converged at ωR(F2)=0.1034 (R(F)=0.0429) for 2554 observed reflections with 
I>2σ(I). 
Crystal data for 5b: (C18H15BF2O4S4); M=472.35. T=150(2) K; monoclinic P 21/c, 
a=14.6844(17), b=12.3494(15), c=11.3986(10) Å, β=102.523(4) °, V=2017.9(4) Å3, Z=4, 
d=1.555 g.cm-3, μ=0.512 mm-1. A final refinement on F2 with 4584 unique intensities and 266 
parameters converged at ωR(F2)=0.1122 (R(F)=0.0523) for 2425 observed reflections with 
I>2σ(I). 
Crystal data for 7: (C8H10N2O3); M=182.18 T=100 K; orthorhombic Pcnb, a=7.5868(5), 
b=14.5439(9), c=14.8425(9) Å, α=β=γ=90.0 °, V=1637.75(18) Å3, Z=8, d=1.478 g.cm-3, 
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μ=0.115 mm-1. A final refinement on F2 with 1870 unique intensities and 126 parameters 
converged at ωR(F2)=0.1255 (R(F)=0.0459) for 1520 observed reflections with I>2σ(I). 
Crystal data for 8a: (C19H18FeN2O3); M=378.2. T=150(2) K; monoclinic P 21/c, a=7.4264(3), 
b=18.3887(8), c=12.2869(5) Å, β=103.5250(10) °, V=1631.39(12) Å3, Z=4, d=1.54 g.cm-3, 
μ=0.946 mm-1. A final refinement on F2 with 3735 unique intensities and 231 parameters 
converged at ωR(F2)=0.0642 (R(F)=0.0258) for 3309 observed reflections with I>2σ(I). 
Crystal data for 9a: (C19H17BF2FeN2O3); M=426.01. T=150(2) K; monoclinic P 1 21/n, 
a=7.0024(12), b=13.757(2), c=18.610(3) Å, β=90.130(8) °, V=1792.7(5) Å3, Z=4, d=1.578 
g.cm-3, μ=0.885 mm-1. A final refinement on F2 with 4072 unique intensities and 256 
parameters converged at ωR(F2)=0.0953 (R(F)=0.0477) for 2797 observed reflections with 
I>2σ(I). 
5. Supplementary data 
Crystallographic data for structural analysis have been deposited with the Cambridge 
Crystallographic Data Centre, CCDC No ??????????????? for compounds 5a, 5b, 7, 8a and 
9a respectively. Copies of this information may be obtained free of charge from The CCDC, 
12 Union Rd, Cambridge CB2 1EZ, UK (fax: +44 1223 336033; e-mail: 
deposit@ccdc.cam.ac.uk or http://www.ccdc.cam.ac.uk).
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